Single nucleotide polymorphism and serum levels of VEGFR2 are associated with age related macular degeneration

Current Neurovascular Research

Volumn 9, Issue 4, 2012, Pages 256-265

  Sharma, Neel Kamal ^a   Gupta, Amod ^a   Prabhakar, Sudesh ^a   Singh, Ramandeep ^a   Sharma, Suresh ^b   Anand, Akshay ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Angiogenesis; Genotype; Macular degeneration; Single neucleotide polymorphism; VEGFR2

Indexed keywords

VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; EXON; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HEREDITY; HISTOPATHOLOGY; HUMAN; INDIAN; MAJOR CLINICAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SERUM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84870431656     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/156720212803530681     Document Type: Article

References (24)

1. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99:933-943.
2. Seo MS, Kwak N, Ozaki H, et al. 1999. Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am. J. Pathol. 154, 1743e1753.
3. Chapman JA, Beckey C, Chapman. Pegaptanib: a novel approach to ocular neo-vascularization. Ann. Pharmacother. 2006;40:1322-1326. (Pubitemid 44204962)
4. Edwards AO. Genetic testing for age-related macular degeneration. Ophthalmology 2006;113:509-510.
5. Seddon JM, George S, Rosner B, Klein ML. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered. 2006;61:157-165. (Pubitemid 44385444)
6. Haddad S, Chen CA, Santangelo SL, Seddon JM. The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol 2006;51:316-363. (Pubitemid 43970736)
7. Carneiro AM, Costa R, Falcao MS, et al. Vascular endothelial growth factor plasma levels before and after treatment of neovascular age-related macular degeneration with bevacizumab or ranibizumab. Acta Ophthalmol. 2011;29:1755-3768.
8. Philipp W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci. 2000;41:2514-2522. (Pubitemid 30624378)
9. Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. ProcNatlAcadSci USA. 1998;95:9349-9354. (Pubitemid 28506234)
10. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 2000;60:203-12. (Pubitemid 30070735)
11. Olsson AK, Dimberg A, Kreuger J and Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Molecular Cell Biology. 2006;7:359-371.
12. Grisanti S, Tatar O. The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration. Prog Retin Eye Res. 2008;27:372-90.
13. Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res. 2008;27:331-71.
14. Boekhoorn SS, Isaacs A, Uitterlinden AG, et al. Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study. Ophthalmology. 2008;115:1899-903.
15. Lin JM, Wan L, Tsai YY, et al. Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. Am J Ophthalmol. 2008;145:1045-51.
16. Churchill AJ, Carter JG, Lovell HC, et al. VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum Mol Genet. 2006;15:2955-61. (Pubitemid 44446814)
17. Fang AM, Lee AY, Kulkarni M, Osborn MP, Brantley MA. Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration. Molecular Vision 2009;15:2710-2719.
18. Sharma NK, Prabhakar S, Anand A. Age related macular degeneration - advances and trends. Annals of Neurosciences. 2009;2:62-71.
19. Ramrattan RS, Schaft TL, Mooy CM, de Bruyn CM, Mulder PGH, de Jong PTVM. Morphometric analysis of Bruch's membrane, the choriocapillaris and the choroid in aging. Invest Ophthalmol Vis Sci 1994;35:2857-64. (Pubitemid 24149800)
20. Pabst S, Karpushova A, Dìaz-Lacava A, et al. VEGF gene haplotypes are associated with sarcoidosis. Chest 2010;137:156-163.
21. Snow KK and Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epedemiology 1999;6:125-143. (Pubitemid 29391400)
22. Carrillo de Santa Pau E, Arias FC, Caso Peláez E, et al. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer. Cancer. 2009;115:1701-12.
23. Dougher M & Terman BI. Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization. Oncogene. 1999;18:1619-1627. (Pubitemid 29108062)
24. Rosenfeld PJ, Heier JS, Hantsbarger G, Shams N. Tolerabil-ity and efficacy of multiple escalating doses of ranibizumab [Lucentis] for neovascular age-related macular degeneration. Ophthalmology 2006;113:623-632.